In conclusion, NLRP3 activation causes IL-1β release, increasing insulin resistance and reducing glucose uptake in target tissues such as liver and adipose tissue, leading to the pathogenesis of diabetes and obesity [69]. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.